Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Tenigipt-MF Tablet ER

Prescription Icon
Prescription Required

Marketer

Aletheia Medicare Pvt Ltd

Salt Composition

Metformin (1000mg) + Teneligliptin (20mg)

Overview Tenigipt-MF Tablet ER

Diabetic patients with type 2 mellitus find effective blood sugar management through Tenigipt-MF Tablet ER, a dual-action medication. This formulation mitigates the risk of severe diabetic complications like kidney failure and vision loss, potentially lowering heart attack and stroke probabilities. Tenigipt-MF Tablet ER may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved when combined with a balanced diet and regular physical activity. Dosage is individualized based on your health status, glucose levels, and concurrent medications. Consuming it with food minimizes gastrointestinal discomfort. Consistent daily dosing, at the same time, maximizes therapeutic benefits; discontinuation should only occur under physician guidance. Effective blood sugar control minimizes future complications. Adherence to your physician's prescribed diet and exercise plan is crucial, as lifestyle choices significantly impact diabetes management. Common side effects include nausea, vomiting, diarrhea, stomach upset, and headaches. Concurrent use with insulin or sulfonylureas may cause hypoglycemia, necessitating awareness of its symptoms and management. This medication isn't suitable for all individuals. Prior to use, inform your physician of any history of kidney, liver, or heart disease; pancreatic issues; or significant alcohol consumption. Pregnant or breastfeeding individuals require medical consultation before use. Potential drug interactions necessitate disclosure of all medications to your doctor. Alcohol consumption should be minimized due to its hypoglycemic effects. Your doctor will monitor kidney function and blood glucose levels throughout treatment.

Uses of Tenigipt-MF Tablet ER

Managing Type 2 Diabetes

Major Benefits of Tenigipt-MF Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Tenigipt-MF Extended-Release Tablets with food.

Common Side effects of Tenigipt-MF Tablet ER:

  • Nausea
  • Vomiting
  • Headache
  • Hypoglycemia (low blood glucose level)
  • Diarrhea

How to use Tenigipt-MF Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Tenigipt-MF Tablet ER. Ingest the tablet whole; do not crush, chew, or break it. Consume this medication with food.

How Tenigipt-MF Tablet ER works:

Extended-release Tenigipt-MF tablets contain a dual antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Tenigipt-MF Tablet ER and alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Tenigipt-MF Tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Tenigipt-MF tablets are likely not safe for use while breastfeeding. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

Driving ability while taking Tenigipt-MF Tablet ER is undetermined. Refrain from driving if you exhibit any symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

Exercise caution when administering Tenigipt-MF Tablet ER to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Tenigipt-MF Tablet ER is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Extended-release Tenigipt-MF tablets are contraindicated for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Tenigipt-MF Tablet ER :

Should you forget a Tenigipt-MF Tablet ER dose, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Tenigipt-MF Tablet ER

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Tenigipt-MF Tablet ER

Tenigipt-MF Tablet ER is safe when used as directed by your doctor. However, even with correct dosage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and hypoglycemia (low blood sugar) may occur. Hypoglycemia is more likely if you're also taking insulin or sulfonylurea. Report any persistent issues to your doctor.
Tenigipt-MF Tablet ER typically doesn't cause low blood sugar (hypoglycemia) by itself. However, hypoglycemia can result from inadequate caloric intake while using this medication. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. These are more likely if you skip meals, drink alcohol, overexert yourself, or take other diabetes medications concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a quick-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Tenigipt-MF Tablet ER. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without your doctor's approval.
Tenigipt-MF Tablet ER is contraindicated in patients allergic to its components or excipients. It should also be avoided in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Tenigipt-MF Tablet ER can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a rare but serious side effect involving elevated blood lactic acid. This risk is higher in patients with kidney disease, the elderly, and heavy alcohol users, who should avoid this medication. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Tenigipt-MF Tablet ER and seek immediate medical attention.
Prolonged use of Tenigipt-MF Tablet ER can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may result in anemia, nerve damage, including tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and balance problems (ataxia). If you experience any of these symptoms, consult your doctor for B12 level monitoring and potential supplementation.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Tenigipt-MF Tablet ER
105
MRP 122
13% off